Alexander Bukreyev - Publications

Affiliations: 
Pathology University of Texas at Galveston Medical Branch 

109 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Ramos I, Goforth C, Soares-Schanoski A, Weir DL, Samuels EC, Phogat S, Meyer M, Huang K, Pietzsch CA, Ge Y, Pike BL, Regeimbal J, Simons MP, Termini MS, Vangeti S, ... ... Bukreyev A, et al. Antibody Responses to SARS-CoV-2 Following an Outbreak Among Marine Recruits With Asymptomatic or Mild Infection. Frontiers in Immunology. 12: 681586. PMID 34177926 DOI: 10.3389/fimmu.2021.681586  0.4
2021 Shiakolas AR, Johnson N, Kramer KJ, Suryadevara N, Wrapp D, Periasamy S, Pilewski KA, Raju N, Nargi R, Sutton RE, Walker L, Crowe JE, Bukreyev A, Carnahan RH, McLellan JS, et al. Efficient discovery of potently neutralizing SARS-CoV-2 antibodies using LIBRA-seq with ligand blocking. Biorxiv : the Preprint Server For Biology. PMID 34100018 DOI: 10.1101/2021.06.02.446813  0.6
2021 Hoehn KB, Ramanathan P, Unterman A, Sumida TS, Asashima H, Hafler DA, Kaminski N, Dela Cruz CS, Sealfon SC, Bukreyev A, Kleinstein SH. Cutting Edge: Distinct B Cell Repertoires Characterize Patients with Mild and Severe COVID-19. Journal of Immunology (Baltimore, Md. : 1950). PMID 34049971 DOI: 10.4049/jimmunol.2100135  0.4
2021 Engdahl TB, Kuzmina NA, Ronk AJ, Mire CE, Hyde MA, Kose N, Josleyn MD, Sutton RE, Mehta A, Wolters RM, Lloyd NM, Valdivieso FR, Ksiazek TG, Hooper JW, Bukreyev A, et al. Broad and potently neutralizing monoclonal antibodies isolated from human survivors of New World hantavirus infection. Cell Reports. 35: 109086. PMID 33951434 DOI: 10.1016/j.celrep.2021.109086  0.6
2021 Letizia AG, Ge Y, Vangeti S, Goforth C, Weir DL, Kuzmina NA, Balinsky CA, Chen HW, Ewing D, Soares-Schanoski A, George MC, Graham WD, Jones F, Bharaj P, Lizewski RA, ... ... Bukreyev A, et al. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study. The Lancet. Respiratory Medicine. PMID 33865504 DOI: 10.1016/S2213-2600(21)00158-2  0.32
2021 Murin CD, Gilchuk P, Ilinykh PA, Huang K, Kuzmina N, Shen X, Bruhn JF, Bryan AL, Davidson E, Doranz BJ, Williamson LE, Copps J, Alkutkar T, Flyak AI, Bukreyev A, et al. Convergence of a common solution for broad ebolavirus neutralization by glycan cap-directed human antibodies. Cell Reports. 35: 108984. PMID 33852862 DOI: 10.1016/j.celrep.2021.108984  0.6
2021 Gunn BM, Lu R, Slein MD, Ilinykh PA, Huang K, Atyeo C, Schendel SL, Kim J, Cain C, Roy V, Suscovich TJ, Takada A, Halfmann PJ, Kawaoka Y, Pauthner MG, ... ... Bukreyev A, et al. A Fc engineering approach to define functional humoral correlates of immunity against Ebola virus. Immunity. 54: 815-828.e5. PMID 33852832 DOI: 10.1016/j.immuni.2021.03.009  0.6
2021 Grand RL, Maisonnasse P, Aldon Y, Marc A, Marlin R, Dereuddre-Bosquet N, Kuzmina N, Freyn A, Snitselaar J, Gonçalves A, Caniels T, Burger J, Poniman M, Chesnais V, Diry S, ... ... Bukreyev A, et al. COVA1-18 neutralizing antibody protects against SARS-CoV-2 in three preclinical models. Research Square. PMID 33619476 DOI: 10.21203/rs.3.rs-235272/v1  0.32
2021 Meyer M, Wang Y, Edwards D, Smith GR, Rubenstein AB, Ramanathan P, Mire CE, Pietzsch C, Chen X, Ge Y, Cheng WS, Henry C, Woods A, Ma L, Stewart-Jones GBE, ... ... Bukreyev A, et al. mRNA-1273 efficacy in a severe COVID-19 model: attenuated activation of pulmonary immune cells after challenge. Biorxiv : the Preprint Server For Biology. PMID 33532780 DOI: 10.1101/2021.01.25.428136  0.4
2021 Atyeo C, Slein MD, Fischinger S, Burke J, Schäfer A, Leist SR, Kuzmina NA, Mire C, Honko A, Johnson R, Storm N, Bernett M, Tong P, Zuo T, Lin J, ... ... Bukreyev A, et al. Dissecting strategies to tune the therapeutic potential of SARS-CoV-2-specific monoclonal antibody CR3022. Jci Insight. 6. PMID 33427208 DOI: 10.1172/jci.insight.143129  0.32
2020 Bozhanova NG, Sangha AK, Sevy AM, Gilchuk P, Huang K, Nargi RS, Reidy JX, Trivette A, Carnahan RH, Bukreyev A, Crowe JE, Meiler J. Discovery of Marburg virus neutralizing antibodies from virus-naïve human antibody repertoires using large-scale structural predictions. Proceedings of the National Academy of Sciences of the United States of America. PMID 33229516 DOI: 10.1073/pnas.1922654117  0.6
2020 Malherbe DC, Domi A, Hauser MJ, Meyer M, Gunn BM, Alter G, Bukreyev A, Guirakhoo F. Modified vaccinia Ankara vaccine expressing Marburg virus-like particles protects guinea pigs from lethal Marburg virus infection. Npj Vaccines. 5: 78. PMID 32922962 DOI: 10.1038/s41541-020-00226-y  0.4
2020 Kuhn JH, Adkins S, Alioto D, Alkhovsky SV, Amarasinghe GK, Anthony SJ, Avšič-Županc T, Ayllón MA, Bahl J, Balkema-Buschmann A, Ballinger MJ, Bartonička T, Basler C, Bavari S, Beer M, ... ... Bukreyev A, et al. 2020 taxonomic update for phylum Negarnaviricota (Riboviria: Orthornavirae), including the large orders Bunyavirales and Mononegavirales. Archives of Virology. PMID 32888050 DOI: 10.1007/S00705-020-04731-2  0.36
2020 Whitfield ZJ, Prasad AN, Ronk AJ, Kuzmin IV, Ilinykh PA, Andino R, Bukreyev A. Species-Specific Evolution of Ebola Virus during Replication in Human and Bat Cells. Cell Reports. 32: 108028. PMID 32814037 DOI: 10.1016/J.Celrep.2020.108028  0.32
2020 Ilinykh PA, Huang K, Santos RI, Gilchuk P, Gunn BM, Karim MM, Liang J, Fouch ME, Davidson E, Parekh DV, Kimble JB, Pietzsch CA, Meyer M, Kuzmina NA, Zeitlin L, ... ... Bukreyev A, et al. Non-neutralizing Antibodies from a Marburg Infection Survivor Mediate Protection by Fc-Effector Functions and by Enhancing Efficacy of Other Antibodies. Cell Host & Microbe. PMID 32320678 DOI: 10.1016/J.Chom.2020.03.025  0.6
2020 Gilchuk P, Murin CD, Milligan JC, Cross RW, Mire CE, Ilinykh PA, Huang K, Kuzmina N, Altman PX, Hui S, Gunn BM, Bryan AL, Davidson E, Doranz BJ, Turner HL, ... ... Bukreyev A, et al. Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization. Immunity. PMID 32023489 DOI: 10.1016/J.Immuni.2020.01.001  0.6
2019 Younan P, Santos RI, Ramanathan P, Iampietro M, Nishida A, Dutta M, Ammosova T, Meyer M, Katze MG, Popov VL, Nekhai S, Bukreyev A. Ebola virus-mediated T-lymphocyte depletion is the result of an abortive infection. Plos Pathogens. 15: e1008068. PMID 31648236 DOI: 10.1371/Journal.Ppat.1008068  0.4
2019 Ivanov A, Ramanathan P, Parry C, Ilinykh PA, Lin X, Petukhov M, Obukhov Y, Ammosova T, Amarasinghe GK, Bukreyev A, Nekhai S. Global phosphoproteomic analysis of Ebola virions reveals a novel role for VP35 phosphorylation-dependent regulation of genome transcription. Cellular and Molecular Life Sciences : Cmls. PMID 31562565 DOI: 10.1007/S00018-019-03303-1  0.4
2019 Amarasinghe GK, Ayllón MA, Bào Y, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chabi-Jesus C, Chandran K, Chiapponi C, Crozier I, et al. Taxonomy of the order Mononegavirales: update 2019. Archives of Virology. PMID 31089958 DOI: 10.1007/S00705-019-04247-4  0.36
2019 King LB, West BR, Moyer CL, Gilchuk P, Flyak A, Ilinykh PA, Bombardi R, Hui S, Huang K, Bukreyev A, Crowe JE, Saphire EO. Cross-reactive neutralizing human survivor monoclonal antibody BDBV223 targets the ebolavirus stalk. Nature Communications. 10: 1788. PMID 30996276 DOI: 10.1038/S41467-019-09732-7  0.6
2019 West BR, Wec AZ, Moyer CL, Fusco ML, Ilinykh PA, Huang K, Wirchnianski AS, James RM, Herbert AS, Hui S, Goodwin E, Howell KA, Kailasan S, Aman MJ, Walker LM, ... ... Bukreyev A, et al. Structural basis of broad ebolavirus neutralization by a human survivor antibody. Nature Structural & Molecular Biology. PMID 30833785 DOI: 10.1038/S41594-019-0191-4  0.6
2019 Maes P, Amarasinghe GK, Ayllón MA, Basler CF, Bavari S, Blasdell KR, Briese T, Brown PA, Bukreyev A, Balkema-Buschmann A, Buchholz UJ, Chandran K, Crozier I, de Swart RL, Dietzgen RG, et al. Taxonomy of the order Mononegavirales: second update 2018. Archives of Virology. PMID 30663023 DOI: 10.1007/S00705-018-04126-4  0.36
2018 Kimble JB, Malherbe DC, Meyer M, Gunn BM, Karim MM, Ilinykh PA, Iampietro M, Mohamed KS, Negi S, Gilchuk P, Huang K, Wolf YI, Braun W, Crowe JE, Alter G, ... Bukreyev A, et al. ANTIBODY-MEDIATED PROTECTIVE MECHANISMS INDUCED BY A TRIVALENT PARAINFLUENZA-VECTORED EBOLAVIRUS VACCINE. Journal of Virology. PMID 30518655 DOI: 10.1128/Jvi.01845-18  0.6
2018 Fang J, Pietzsch C, Ramanathan P, Santos RI, Ilinykh PA, Garcia-Blanco MA, Bukreyev A, Bradrick SS. Staufen1 Interacts with Multiple Components of the Ebola Virus Ribonucleoprotein and Enhances Viral RNA Synthesis. Mbio. 9. PMID 30301857 DOI: 10.1128/Mbio.01771-18  0.4
2018 Younan P, Iampietro M, Santos RI, Ramanathan P, Popov VL, Bukreyev A. Role of Transmembrane Protein 16F in the Incorporation of Phosphatidylserine Into Budding Ebola Virus Virions. The Journal of Infectious Diseases. PMID 30289531 DOI: 10.1093/Infdis/Jiy485  0.4
2018 Younan P, Iampietro M, Santos RI, Ramanathan P, Popov VL, Bukreyev A. Disruption of Phosphatidylserine Synthesis or Trafficking Reduces Infectivity of Ebola Virus. The Journal of Infectious Diseases. PMID 30289506 DOI: 10.1093/Infdis/Jiy489  0.4
2018 Meyer M, Malherbe DC, Bukreyev A. Can Ebola Virus Vaccines Have Universal Immune Correlates of protection? Trends in Microbiology. PMID 30201511 DOI: 10.1016/J.Tim.2018.08.008  0.4
2018 Ilinykh PA, Santos RI, Gunn BM, Kuzmina NA, Shen X, Huang K, Gilchuk P, Flyak AI, Younan P, Alter G, Crowe JE, Bukreyev A. Asymmetric antiviral effects of ebolavirus antibodies targeting glycoprotein stem and glycan cap. Plos Pathogens. 14: e1007204. PMID 30138408 DOI: 10.1371/Journal.Ppat.1007204  0.6
2018 Tigabu B, Ramanathan P, Ivanov A, Lin X, Ilinykh PA, Parry CS, Freiberg AN, Nekhai S, Bukreyev A. PHOSPHORYLATED VP30 OF MARBURG VIRUS IS A REPRESSOR OF TRANSCRIPTION. Journal of Virology. PMID 30135121 DOI: 10.1128/Jvi.00426-18  0.4
2018 Meyer M, Yoshida A, Ramanathan P, Saphire EO, Collins PL, Crowe JE, Samal S, Bukreyev A. Antibody Repertoires to the Same Ebola Vaccine Antigen Are Differentially Affected by Vaccine Vectors. Cell Reports. 24: 1816-1829. PMID 30110638 DOI: 10.1016/J.Celrep.2018.07.044  0.76
2018 Kuzmina NA, Younan P, Gilchuk P, Santos RI, Flyak AI, Ilinykh PA, Huang K, Lubaki NM, Ramanathan P, Crowe JE, Bukreyev A. Antibody-Dependent Enhancement of Ebola Virus Infection by Human Antibodies Isolated from Survivors. Cell Reports. 24: 1802-1815.e5. PMID 30110637 DOI: 10.1016/J.Celrep.2018.07.035  0.6
2018 Ilinykh PA, Graber J, Kuzmina NA, Huang K, Ksiazek TG, Crowe JE, Bukreyev A. Ebolavirus Chimerization for the Development of a Mouse Model for Screening of Bundibugyo-Specific Antibodies. The Journal of Infectious Diseases. PMID 30060231 DOI: 10.1093/Infdis/Jiy423  0.6
2018 Gilchuk P, Kuzmina N, Ilinykh PA, Huang K, Gunn BM, Bryan A, Davidson E, Doranz BJ, Turner HL, Fusco ML, Bramble MS, Hoff NA, Binshtein E, Kose N, Flyak AI, ... ... Bukreyev A, et al. Multifunctional Pan-ebolavirus Antibody Recognizes a Site of Broad Vulnerability on the Ebolavirus Glycoprotein. Immunity. PMID 30029854 DOI: 10.1016/J.Immuni.2018.06.018  0.6
2018 Flyak AI, Kuzmina N, Murin CD, Bryan C, Davidson E, Gilchuk P, Gulka CP, Ilinykh PA, Shen X, Huang K, Ramanathan P, Turner H, Fusco ML, Lampley R, Kose N, ... ... Bukreyev A, et al. Broadly neutralizing antibodies from human survivors target a conserved site in the Ebola virus glycoprotein HR2-MPER region. Nature Microbiology. PMID 29736037 DOI: 10.1038/S41564-018-0157-Z  0.6
2018 Pleet ML, Mathiesen A, DeMarino C, Akpamagbo YA, Barclay RA, Schwab A, Iordanskiy S, Sampey GC, Lepene B, Ilinykh PA, Bukreyev A, Nekhai S, Aman MJ, Kashanchi F. Corrigendum: Ebola VP40 in Exosomes Can Cause Immune Cell Dysfunction. Frontiers in Microbiology. 9: 692. PMID 29696006 DOI: 10.3389/Fmicb.2018.00692  0.32
2018 Amarasinghe GK, Aréchiga Ceballos NG, Banyard AC, Basler CF, Bavari S, Bennett AJ, Blasdell KR, Briese T, Bukreyev A, Caì Y, Calisher CH, Campos Lawson C, Chandran K, Chapman CA, Chiu CY, et al. Taxonomy of the order Mononegavirales: update 2018. Archives of Virology. PMID 29637429 DOI: 10.1007/S00705-018-3814-X  0.76
2018 King LB, Fusco ML, Flyak AI, Ilinykh PA, Huang K, Gunn B, Kirchdoerfer RN, Hastie KM, Sangha AK, Meiler J, Alter G, Bukreyev A, Crowe JE, Saphire EO. The Marburgvirus-Neutralizing Human Monoclonal Antibody MR191 Targets a Conserved Site to Block Virus Receptor Binding. Cell Host & Microbe. 23: 101-109.e4. PMID 29324225 DOI: 10.1016/J.Chom.2017.12.003  0.6
2017 Meyer M, Huang E, Yuzhakov O, Ramanathan P, Ciaramella G, Bukreyev A. Modified mRNA-Based Vaccines Elicit Robust Immune Responses and Protect Guinea Pigs From Ebola Virus Disease. The Journal of Infectious Diseases. PMID 29281112 DOI: 10.1093/Infdis/Jix592  0.4
2017 Younan P, Iampietro M, Nishida A, Ramanathan P, Santos RI, Dutta M, Lubaki NM, Koup RA, Katze MG, Bukreyev A. Ebola Virus Binding to Tim-1 on T Lymphocytes Induces a Cytokine Storm. Mbio. 8. PMID 28951472 DOI: 10.1128/Mbio.00845-17  0.4
2017 Younan P, Ramanathan P, Graber J, Gusovsky F, Bukreyev A. The Toll-Like Receptor 4 Antagonist Eritoran Protects Mice from Lethal Filovirus Challenge. Mbio. 8. PMID 28442605 DOI: 10.1128/Mbio.00226-17  0.4
2017 Amarasinghe GK, Bào Y, Basler CF, Bavari S, Beer M, Bejerman N, Blasdell KR, Bochnowski A, Briese T, Bukreyev A, Calisher CH, Chandran K, Collins PL, Dietzgen RG, Dolnik O, et al. Taxonomy of the order Mononegavirales: update 2017. Archives of Virology. PMID 28389807 DOI: 10.1007/S00705-017-3311-7  0.76
2017 Kuzmin IV, Schwarz TM, Ilinykh PA, Jordan I, Ksiazek TG, Sachidanandam R, Basler CF, Bukreyev A. Innate Immune Response of Bat and Human Cells to Filoviruses: Commonalities and Distinctions. Journal of Virology. PMID 28122983 DOI: 10.1128/Jvi.02471-16  0.44
2016 Lubaki NM, Younan P, Santos RI, Meyer M, Iampietro M, Koup RA, Bukreyev A. The Ebola Interferon Inhibiting Domains Attenuate and Dysregulate Cell-Mediated Immune Responses. Plos Pathogens. 12: e1006031. PMID 27930745 DOI: 10.1371/Journal.Ppat.1006031  0.4
2016 Postler TS, Clawson AN, Amarasinghe GK, Basler CF, Bavari S, Benkő M, Blasdell KR, Briese T, Buchmeier MJ, Bukreyev A, Calisher CH, Chandran K, Charrel R, Clegg CS, Collins PL, et al. Possibility and Challenges of Conversion of Current Virus Species Names to Linnaean Binomials. Systematic Biology. PMID 27798405 DOI: 10.1093/Sysbio/Syw096  0.76
2016 Norris EL, Headlam MJ, Dave KA, Smith DD, Bukreyev A, Singh T, Jayakody BA, Chappell KJ, Collins PL, Gorman JJ. Proteoform-specific insights into cellular proteome regulation. Molecular & Cellular Proteomics : McP. PMID 27451424 DOI: 10.1074/Mcp.O116.058438  0.76
2016 Afonso CL, Amarasinghe GK, Bányai K, Bào Y, Basler CF, Bavari S, Bejerman N, Blasdell KR, Briand FX, Briese T, Bukreyev A, Calisher CH, Chandran K, Chéng J, Clawson AN, et al. Taxonomy of the order Mononegavirales: update 2016. Archives of Virology. PMID 27216929 DOI: 10.1007/S00705-016-2880-1  0.76
2016 Rialdi A, Campisi L, Zhao N, Lagda AC, Pietzsch C, Ho JS, Martinez-Gil L, Fenouil R, Chen X, Edwards M, Metreveli G, Jordan S, Peralta Z, Munoz-Fontela C, Bouvier N, ... ... Bukreyev A, et al. Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation. Science (New York, N.Y.). PMID 27127234 DOI: 10.1126/Science.Aad7993  0.76
2016 Ilinykh PA, Shen X, Flyak AI, Kuzmina N, Ksiazek TG, Crowe JE, Bukreyev A. Chimeric Filoviruses for Identification and Characterization of Monoclonal Antibodies. Journal of Virology. PMID 26819310 DOI: 10.1128/Jvi.00101-16  0.76
2016 Flyak AI, Shen X, Murin CD, Turner HL, David JA, Fusco ML, Lampley R, Kose N, Ilinykh PA, Kuzmina N, Branchizio A, King H, Brown L, Bryan C, Davidson E, ... ... Bukreyev A, et al. Cross-Reactive and Potent Neutralizing Antibody Responses in Human Survivors of Natural Ebolavirus Infection. Cell. PMID 26806128 DOI: 10.1016/J.Cell.2015.12.022  0.76
2015 Meyer M, Garron T, Lubaki NM, Mire CE, Fenton KA, Klages C, Olinger GG, Geisbert TW, Collins PL, Bukreyev A. Aerosolized Ebola vaccine protects primates and elicits lung-resident T cell responses. The Journal of Clinical Investigation. 125: 3241-55. PMID 26168222 DOI: 10.1172/Jci81532  0.76
2015 Russell RF, McDonald JU, Ivanova M, Zhong Z, Bukreyev A, Tregoning JS. The partial attenuation of Small Hydrophobic (SH) gene deleted RSV is associated with elevated IL-1β responses. Journal of Virology. PMID 26085154 DOI: 10.1128/Jvi.01070-15  0.76
2015 Ilinykh PA, Lubaki NM, Widen SG, Renn LA, Theisen TC, Rabin RL, Wood TG, Bukreyev A. Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells. Journal of Virology. 89: 7567-83. PMID 25972536 DOI: 10.1128/Jvi.00924-15  0.76
2015 Flyak AI, Ilinykh PA, Murin CD, Garron T, Shen X, Fusco ML, Hashiguchi T, Bornholdt ZA, Slaughter JC, Sapparapu G, Klages C, Ksiazek TG, Ward AB, Saphire EO, Bukreyev A, et al. Mechanism of human antibody-mediated neutralization of Marburg virus. Cell. 160: 893-903. PMID 25723164 DOI: 10.1016/J.Cell.2015.01.031  0.76
2015 Rasmussen L, Tigabu B, White EL, Bostwick R, Tower N, Bukreyev A, Rockx B, LeDuc JW, Noah JW. Adapting high-throughput screening methods and assays for biocontainment laboratories. Assay and Drug Development Technologies. 13: 44-54. PMID 25710545 DOI: 10.1089/Adt.2014.617  0.76
2014 Kuhn JH, Andersen KG, Bào Y, Bavari S, Becker S, Bennett RS, Bergman NH, Blinkova O, Bradfute S, Brister JR, Bukreyev A, Chandran K, Chepurnov AA, Davey RA, Dietzgen RG, et al. Filovirus RefSeq entries: evaluation and selection of filovirus type variants, type sequences, and names. Viruses. 6: 3663-82. PMID 25256396 DOI: 10.3390/V6093663  0.76
2014 Dave KA, Norris EL, Bukreyev AA, Headlam MJ, Buchholz UJ, Singh T, Collins PL, Gorman JJ. A comprehensive proteomic view of responses of A549 type II alveolar epithelial cells to human respiratory syncytial virus infection. Molecular & Cellular Proteomics : McP. 13: 3250-69. PMID 25106423 DOI: 10.1074/mcp.M114.041129  0.76
2014 Ilinykh PA, Tigabu B, Ivanov A, Ammosova T, Obukhov Y, Garron T, Kumari N, Kovalskyy D, Platonov MO, Naumchik VS, Freiberg AN, Nekhai S, Bukreyev A. Role of protein phosphatase 1 in dephosphorylation of Ebola virus VP30 protein and its targeting for the inhibition of viral transcription. The Journal of Biological Chemistry. 289: 22723-38. PMID 24936058 DOI: 10.1074/Jbc.M114.575050  0.44
2014 Kuhn JH, Bào Y, Bavari S, Becker S, Bradfute S, Brauburger K, Rodney Brister J, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, et al. Virus nomenclature below the species level: a standardized nomenclature for filovirus strains and variants rescued from cDNA. Archives of Virology. 159: 1229-37. PMID 24190508 DOI: 10.1007/S00705-013-1877-2  0.76
2014 Bukreyev AA, Chandran K, Dolnik O, Dye JM, Ebihara H, Leroy EM, Mühlberger E, Netesov SV, Patterson JL, Paweska JT, Saphire EO, Smither SJ, Takada A, Towner JS, Volchkov VE, et al. Discussions and decisions of the 2012–2014 International Committee on Taxonomy of Viruses (ICTV) Filoviridae Study Group, January 2012–June 2013. Archives of Virology. 159: 821-30. PMID 24122154 DOI: 10.1007/S00705-013-1846-9  0.76
2013 Tregoning JS, Wang BL, McDonald JU, Yamaguchi Y, Harker JA, Goritzka M, Johansson C, Bukreyev A, Collins PL, Openshaw PJ. Neonatal antibody responses are attenuated by interferon-γ produced by NK and T cells during RSV infection. Proceedings of the National Academy of Sciences of the United States of America. 110: 5576-81. PMID 23509276 DOI: 10.1073/Pnas.1214247110  0.76
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Caì Y, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Gonzalez JP, Formenty P, et al. Virus nomenclature below the species level: a standardized nomenclature for laboratory animal-adapted strains and variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 1425-32. PMID 23358612 DOI: 10.1007/S00705-012-1594-2  0.76
2013 Kuhn JH, Bao Y, Bavari S, Becker S, Bradfute S, Brister JR, Bukreyev AA, Chandran K, Davey RA, Dolnik O, Dye JM, Enterlein S, Hensley LE, Honko AN, Jahrling PB, et al. Virus nomenclature below the species level: a standardized nomenclature for natural variants of viruses assigned to the family Filoviridae. Archives of Virology. 158: 301-11. PMID 23001720 DOI: 10.1007/S00705-012-1454-0  0.76
2012 Bukreyev A, Yang L, Collins PL. The secreted G protein of human respiratory syncytial virus antagonizes antibody-mediated restriction of replication involving macrophages and complement. Journal of Virology. 86: 10880-4. PMID 22837211 DOI: 10.1128/Jvi.01162-12  0.76
2012 Hastie ML, Headlam MJ, Patel NB, Bukreyev AA, Buchholz UJ, Dave KA, Norris EL, Wright CL, Spann KM, Collins PL, Gorman JJ. The human respiratory syncytial virus nonstructural protein 1 regulates type I and type II interferon pathways. Molecular & Cellular Proteomics : McP. 11: 108-27. PMID 22322095 DOI: 10.1074/mcp.M111.015909  0.76
2011 Munir S, Hillyer P, Le Nouën C, Buchholz UJ, Rabin RL, Collins PL, Bukreyev A. Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response. Plos Pathogens. 7: e1001336. PMID 21533073 DOI: 10.1371/Journal.Ppat.1001336  0.76
2010 Le Nouën C, Hillyer P, Munir S, Winter CC, McCarty T, Bukreyev A, Collins PL, Rabin RL, Buchholz UJ. Effects of human respiratory syncytial virus, metapneumovirus, parainfluenza virus 3 and influenza virus on CD4+ T cell activation by dendritic cells. Plos One. 5: e15017. PMID 21124776 DOI: 10.1371/Journal.Pone.0015017  0.76
2010 DiNapoli JM, Yang L, Samal SK, Murphy BR, Collins PL, Bukreyev A. Respiratory tract immunization of non-human primates with a Newcastle disease virus-vectored vaccine candidate against Ebola virus elicits a neutralizing antibody response. Vaccine. 29: 17-25. PMID 21034822 DOI: 10.1016/J.Vaccine.2010.10.024  0.76
2010 Harker JA, Lee DC, Yamaguchi Y, Wang B, Bukreyev A, Collins PL, Tregoning JS, Openshaw PJ. Delivery of cytokines by recombinant virus in early life alters the immune response to adult lung infection. Journal of Virology. 84: 5294-302. PMID 20200251 DOI: 10.1128/Jvi.02503-09  0.76
2010 Harker JA, Godlee A, Wahlsten JL, Lee DC, Thorne LG, Sawant D, Tregoning JS, Caspi RR, Bukreyev A, Collins PL, Openshaw PJ. Interleukin 18 coexpression during respiratory syncytial virus infection results in enhanced disease mediated by natural killer cells. Journal of Virology. 84: 4073-82. PMID 20130064 DOI: 10.1128/Jvi.02014-09  0.76
2010 Bukreyev AA, Dinapoli JM, Yang L, Murphy BR, Collins PL. Mucosal parainfluenza virus-vectored vaccine against Ebola virus replicates in the respiratory tract of vector-immune monkeys and is immunogenic. Virology. 399: 290-8. PMID 20129638 DOI: 10.1016/j.virol.2010.01.015  0.76
2010 Bukreyev A, Collins PL. Filovirus vaccines: what challenges are left? Expert Review of Vaccines. 9: 5-8. PMID 20021298 DOI: 10.1586/Erv.09.150  0.76
2010 DiNapoli JM, Nayak B, Yang L, Finneyfrock BW, Cook A, Andersen H, Torres-Velez F, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic avian influenza virus protect against virus challenge in monkeys. Journal of Virology. 84: 1489-503. PMID 19923177 DOI: 10.1128/Jvi.01946-09  0.76
2009 DiNapoli JM, Ward JM, Cheng L, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Delivery to the lower respiratory tract is required for effective immunization with Newcastle disease virus-vectored vaccines intended for humans. Vaccine. 27: 1530-9. PMID 19168110 DOI: 10.1016/J.Vaccine.2009.01.009  0.76
2009 Le Nouën C, Munir S, Losq S, Winter CC, McCarty T, Stephany DA, Holmes KL, Bukreyev A, Rabin RL, Collins PL, Buchholz UJ. Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3. Virology. 385: 169-82. PMID 19128816 DOI: 10.1016/J.Virol.2008.11.043  0.76
2009 Bukreyev A, Marzi A, Feldmann F, Zhang L, Yang L, Ward JM, Dorward DW, Pickles RJ, Murphy BR, Feldmann H, Collins PL. Chimeric human parainfluenza virus bearing the Ebola virus glycoprotein as the sole surface protein is immunogenic and highly protective against Ebola virus challenge. Virology. 383: 348-61. PMID 19010509 DOI: 10.1016/J.Virol.2008.09.030  0.76
2008 Bukreyev A, Yang L, Fricke J, Cheng L, Ward JM, Murphy BR, Collins PL. The secreted form of respiratory syncytial virus G glycoprotein helps the virus evade antibody-mediated restriction of replication by acting as an antigen decoy and through effects on Fc receptor-bearing leukocytes Journal of Virology. 82: 12191-12204. PMID 18842713 DOI: 10.1128/Jvi.01604-08  0.76
2008 DiNapoli JM, Murphy BR, Collins PL, Bukreyev A. Impairment of the CD8+ T cell response in lungs following infection with human respiratory syncytial virus is specific to the anatomical site rather than the virus, antigen, or route of infection Virology Journal. 5. PMID 18816384 DOI: 10.1186/1743-422X-5-105  0.76
2008 Collins PL, Bukreyev A, Murphy BR. What are the risks - hypothetical and observed - of recombination involving live vaccines and vaccine vectors based on nonsegmented negative-strain RNA viruses? Journal of Virology. 82: 9805-9806. PMID 18796655 DOI: 10.1128/Jvi.01336-08  0.76
2008 Yang L, Sanchez A, Ward JM, Murphy BR, Collins PL, Bukreyev A. A paramyxovirus-vectored intranasal vaccine against Ebola virus is immunogenic in vector-immune animals Virology. 377: 255-264. PMID 18570964 DOI: 10.1016/J.Virol.2008.04.029  0.76
2008 Munir S, Le Nouen C, Luongo C, Buchholz UJ, Collins PL, Bukreyev A. Nonstructural proteins 1 and 2 of respiratory syncytial virus suppress maturation of human dendritic cells. Journal of Virology. 82: 8780-96. PMID 18562519 DOI: 10.1128/Jvi.00630-08  0.76
2008 Bukreyev A, Collins PL. Newcastle disease virus as a vaccine vector for humans Current Opinion in Molecular Therapeutics. 10: 46-55. PMID 18228181  0.76
2007 Harker J, Bukreyev A, Collins PL, Wang B, Openshaw PJM, Tregoning JS. Virally delivered cytokines alter the immune response to future lung infections Journal of Virology. 81: 13105-13111. PMID 17855518 DOI: 10.1128/Jvi.01544-07  0.76
2007 DiNapoli JM, Yang L, Suguitan A, Elankumaran S, Dorward DW, Murphy BR, Samal SK, Collins PL, Bukreyev A. Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus. Journal of Virology. 81: 11560-8. PMID 17715243 DOI: 10.1128/Jvi.00713-07  0.76
2007 DiNapoli JM, Kotelkin A, Yang L, Elankumaran S, Murphy BR, Samal SK, Collins PL, Bukreyev A. Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens. Proceedings of the National Academy of Sciences of the United States of America. 104: 9788-93. PMID 17535926 DOI: 10.1073/Pnas.0703584104  0.76
2007 Bukreyev A, Rollin PE, Tate MK, Yang L, Zaki SR, Shieh WJ, Murphy BR, Collins PL, Sanchez A. Successful topical respiratory tract immunization of primates against Ebola virus. Journal of Virology. 81: 6379-88. PMID 17428868 DOI: 10.1128/Jvi.00105-07  0.76
2007 Collins PL, Bukreyev A. Advances in the development of vaccines against Marburg and Ebola viruses Future Virology. 2: 537-541. DOI: 10.2217/17460794.2.6.537  0.76
2006 Bukreyev A, Skiadopoulos MH, Murphy BR, Collins PL. Nonsegmented negative-strand viruses as vaccine vectors Journal of Virology. 80: 10293-10306. PMID 17041210 DOI: 10.1128/Jvi.00919-06  0.76
2006 Kotelkin A, Belyakov IM, Yang L, Berzofsky JA, Collins PL, Bukreyev A. The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response Journal of Virology. 80: 5958-5967. PMID 16731934 DOI: 10.1128/Jvi.00181-06  0.76
2006 Bukreyev A, Serra ME, Laham FR, Melendi GA, Kleeberger SR, Collins PL, Polack FP. The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T-lymphocyte response despite lacking major histocompatibility complex class I-restricted epitopes Journal of Virology. 80: 5854-5861. PMID 16731924 DOI: 10.1128/Jvi.02671-05  0.76
2006 Bukreyev A, Yang L, Zaki SR, Shieh WJ, Rollin PE, Murphy BR, Collins PL, Sanchez A. A single intranasal inoculation with a paramyxovirus-vectored vaccine protects guinea pigs against a lethal-dose Ebola virus challenge. Journal of Virology. 80: 2267-79. PMID 16474134 DOI: 10.1128/Jvi.80.5.2267-2279.2006  0.76
2006 Kotelkin A, Belyakov IM, Yang L, Berzofsky JA, Collins PL, Bukreyev A. Erratum: The NS2 protein of human respiratory syncytial virus suppresses the cytotoxic T-cell response as a consequence of suppressing the type I interferon response (Journal of Virology (2006) 80, 12 (5958-5967)) Journal of Virology. 80. DOI: 10.1128/Jvi.01773-06  0.76
2005 Bukreyev A, Huang Z, Yang L, Elankumaran S, St Claire M, Murphy BR, Samal SK, Collins PL. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates. Journal of Virology. 79: 13275-84. PMID 16227250 DOI: 10.1128/Jvi.79.21.13275-13284.2005  0.76
2005 Bukreyev A, Belyakov IM, Prince GA, Yim KC, Harris KK, Berzofsky JA, Collins PL. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus. Journal of Virology. 79: 9515-26. PMID 16014914 DOI: 10.1128/Jvi.79.15.9515-9526.2005  0.76
2005 Zhang L, Bukreyev A, Thompson CI, Watson B, Peeples ME, Collins PL, Pickles RJ. Infection of ciliated cells by human parainfluenza virus type 3 in an in vitro model of human airway epithelium. Journal of Virology. 79: 1113-24. PMID 15613339 DOI: 10.1128/Jvi.79.2.1113-1124.2005  0.76
2004 Bukreyev A, Lamirande EW, Buchholz UJ, Vogel LN, Elkins WR, St Claire M, Murphy BR, Subbarao K, Collins PL. Mucosal immunisation of African green monkeys (Cercopithecus aethiops) with an attenuated parainfluenza virus expressing the SARS coronavirus spike protein for the prevention of SARS. Lancet (London, England). 363: 2122-7. PMID 15220033 DOI: 10.1016/S0140-6736(04)16501-X  0.76
2004 Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. Proceedings of the National Academy of Sciences of the United States of America. 101: 9804-9. PMID 15210961 DOI: 10.1073/Pnas.0403492101  0.76
2004 Bisht H, Roberts A, Vogel L, Bukreyev A, Collins PL, Murphy BR, Subbarao K, Moss B. Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice. Proceedings of the National Academy of Sciences of the United States of America. 101: 6641-6. PMID 15096611 DOI: 10.1073/Pnas.0401939101  0.76
2004 Zhang L, Button B, Skiadopoulos MH, Dang Y, Bukreyev A, Gabriel SE, Collins PL, Pickles RJ. 687. Parainfluenza virus-mediated delivery of CFTR to ciliated cells corrects the CF bioelectrical chloride secretory defect and restores the regulation of airway surface liquid depth and mucus transport to cystic fibrosis airway epithelium Molecular Therapy. 9. DOI: 10.1016/J.Ymthe.2004.06.584  0.76
2003 Kotelkin A, Prikhod'ko EA, Cohen JI, Collins PL, Bukreyev A. Respiratory syncytial virus infection sensitizes cells to apoptosis mediated by tumor necrosis factor-related apoptosis-inducing ligand. Journal of Virology. 77: 9156-72. PMID 12915532 DOI: 10.1128/jvi.77.17.9156-9172.2003  0.76
2002 Bukreyev A, Belyakov IM. Expression of immunomodulating molecules by recombinant viruses: can the immunogenicity of live virus vaccines be improved? Expert Review of Vaccines. 1: 233-45. PMID 12901562 DOI: 10.1586/14760584.1.2.233  0.4
2002 Bukreyev A, Skiadopoulos MH, McAuliffe J, Murphy BR, Collins PL, Schmidt AC. More antibody with less antigen: Can immunogenicity of attenuated live virus vaccines be improved? Proceedings of the National Academy of Sciences of the United States of America. 99: 16987-16991. PMID 12482928 DOI: 10.1073/Pnas.252649299  0.76
2001 Bukreyev A, Belyakov IM, Berzofsky JA, Murphy BR, Collins PL. Granulocyte-Macrophage Colony-Stimulating Factor Expressed by Recombinant Respiratory Syncytial Virus Attenuates Viral Replication and Increases the Level of Pulmonary Antigen-Presenting Cells Journal of Virology. 75: 12128-12140. PMID 11711604 DOI: 10.1128/Jvi.75.24.12128-12140.2001  0.76
2000 Bukreyev A, Murphy BR, Collins PL. Respiratory Syncytial Virus Can Tolerate an Intergenic Sequence of at Least 160 Nucleotides with Little Effect on Transcription or Replication In Vitro and In Vivo Journal of Virology. 74: 11017-11026. PMID 11069997 DOI: 10.1128/Jvi.74.23.11017-11026.2000  0.76
2000 Bukreyev A, Whitehead SS, Prussin C, Murphy BR, Collins PL. Effect of coexpression of interleukin-2 by recombinant respiratory syncytial virus on virus replication, immunogenicity, and production of other cytokines. Journal of Virology. 74: 7151-7. PMID 10888656 DOI: 10.1128/Jvi.74.15.7151-7157.2000  0.76
1999 Collins PL, Whitehead SS, Bukreyev A, Fearns R, Teng MN, Juhasz K, Chanock RM, Murphy BR. Rational design of live-attenuated recombinant vaccine virus for human respiratory syncytial virus by reverse genetics. Advances in Virus Research. 54: 423-51. PMID 10547682 DOI: 10.1016/S0065-3527(08)60374-7  0.76
1999 Whitehead SS, Bukreyev A, Teng MN, Firestone CY, St Claire M, Elkins WR, Collins PL, Murphy BR. Recombinant respiratory syncytial virus bearing a deletion of either the NS2 or SH gene is attenuated in chimpanzees. Journal of Virology. 73: 3438-42. PMID 10074199 DOI: 10.1128/Jvi.73.4.3438-3442.1999  0.76
1999 Bukreyev A, Whitehead SS, Bukreyeva N, Murphy BR, Collins PL. Interferon gamma expressed by a recombinant respiratory syncytial virus attenuates virus replication in mice without compromising immunogenicity. Proceedings of the National Academy of Sciences of the United States of America. 96: 2367-72. PMID 10051648 DOI: 10.1073/Pnas.96.5.2367  0.76
1997 Bukreyev A, Whitehead SS, Murphy BR, Collins PL. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. Journal of Virology. 71: 8973-82. PMID 9371553 DOI: 10.1128/Jvi.71.12.8973-8982.1997  0.76
1996 Bukreyev A, Camargo E, Collins PL. Recovery of Infectious Respiratory Syncytial Virus Expressing an Additional, Foreign Gene Journal of Virology. 70: 6634-6641. PMID 8794298 DOI: 10.1128/Jvi.70.10.6634-6641.1996  0.76
Show low-probability matches.